A randomized control trial of anticoagulation [fondaparinux sodium] and inferior vena cava filters in cancer patients with a venous thromboembolism.

Trial Profile

A randomized control trial of anticoagulation [fondaparinux sodium] and inferior vena cava filters in cancer patients with a venous thromboembolism.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 May 2016

At a glance

  • Drugs Fondaparinux sodium (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 02 May 2016 Trial focus has changed from TU to TU and AR
    • 01 Nov 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 02 Mar 2010 Planned end date changed from 1 Dec 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top